|
Match
|
Document |
Document Title |
|
|
7157101 |
Micronized eplerenone compositions
The invention relates to oral pharmaceutical compositions useful as aldosterone receptor blockers comprising the active agent micronized eplerenone in an amount of about 10 mg to about 1000 mg and...
|
|
|
7157103 |
Pharmaceutical formulation containing irritant
Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating...
|
|
|
7150623 |
Tablets containing heat sensitive materials and method for forming thereof
The present invention provides a process and apparatus for preserving the potency of a tableted heat sensitive ingredient. The process includes the steps of forming the ingredient into a tablet and...
|
|
|
7147868 |
Antacid and laxative tablets
An antacid and laxative tablet comprising magnesium oxide particles as an effective component, wherein
(i) the magnesium oxide particles contained in the tablet have an average secondary particle...
|
|
|
7147859 |
Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
It relates to an Association of chemical agents, with intended pharmacological action to prevent the risk of infarction and brain hemorrhage caused by the development of the atherosclerotic process...
|
|
|
7147869 |
Rapidly disintegrating tablet comprising an acid-labile active ingredient
A rapidly disintegrating tablet for oral administration of acid-labile active ingredients is described. The rapidly disintegrating tablet for oral administration of an acid-labile active ingredient...
|
|
|
7144586 |
Compositions for preventing hormone induced adverse effects
A unit dosage form suitable for once daily administration to a human comprising a physiologically effective amount of at least one hormone selected from the group consisting of steroidal estrogen,...
|
|
|
7144880 |
Compositions relating to novel compounds and targets thereof
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and...
|
|
|
7144587 |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic; an opioid antagonist; and a bittering agent in an effective amount to...
|
|
|
7144584 |
S(+) desmethylselegiline and its use to treat narcolepsy
The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of...
|
|
|
7141249 |
Rapidly soluble drug composition
A fast-dissolving pharmaceutical composition comprising micronized (R)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2
-a]pyrazine-4-spiro-3′-pyrrolidine-1,2′,3,5′-tetrone...
|
|
|
7141250 |
Pharmaceutical formulation containing bittering agent
Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of a bittering agent to impart a bitter...
|
|
|
7138138 |
Pharmaceutical formulation having a masked taste and method for the production thereof
The invention relates to a pharmaceutical formulation in the form of a powder which is administered orally in an aqueous suspension, having a masked taste, and comprising at least one cellulose...
|
|
|
7138150 |
Method of making an anti-infective composition for treating oral infections
This invention concerns a method of making an anti-infective composition for oral administration using an agent selected from the group consisting of lactoferrin protein and lysozyme protein. The...
|
|
|
7138137 |
Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
Provided are formulations of a stable paroxetine hydrochloride tablet comprising paroxetine hydrochloride, povidone or copovidone as a binder, and an HCl free/non-hygroscopic filler, prepared by...
|
|
|
7138149 |
Dietary supplements and methods for treating pain and inflammation
The invention provides compositions such as dietary supplements. Such compositions can be used to reduce pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions...
|
|
|
7132114 |
Rapidly disintegrating methylcellulose tablets
The present invention relates to a novel pharmaceutical composition and process for preparing swallowable methylcellulose tablets that disintegrate rapidly and meet USP disintegration standards in...
|
|
|
7125563 |
Sustained release pharmaceutical preparations and methods for producing the same
An extended release tablet comprising a core including albuterol sulfate and extended release agent; and an extended release coating on the core to provide for sustained release of the albuterol...
|
|
|
7125562 |
Rapidly disintegrating methylcellulose tablets
The present invention relates to a rapidly disintegrating tablet for oral administration. The tablet has a first phase and a second phase blended with the first phase. The first phase has a...
|
|
|
7125567 |
Process for producing an oral sustained-release preparation of fasudil hydrochloride
Disclosed is an oral sustained-release preparation which contains at least one active ingredient selected from the group consisting of fasudil hydrochloride and a hydrate thereof, the preparation...
|
|
|
7122198 |
Fast dissolving composition with prolonged sweet taste
A novel fast dissolving pharmaceutical composition in solid dosage form with prolonged sweet taste which comprises (a) At least one pharmaceutically active agent, (b) At least one water soluble...
|
|
|
7122203 |
Stabilized formulations of 6-hydroxy-3-(-4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof
The present invention is directed to pharmaceutical formulations containing 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-metho
xypheny)benzo[b]thiophene or a salt thereof; stabilized to...
|
|
|
7122204 |
Antibiotic composition with inhibitor
Antibiotic composition having four dosage forms with different release profiles providing for initial release of a beta lactam antibiotic followed by release of a beta-lactamase inhibitor, followed...
|
|
|
7118765 |
Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
The present invention comprises a co-processed carbohydrate system, and formulations produced therefrom, which formulations are directly compressible into solid dosage forms, some of which rapidly...
|
|
|
7118762 |
Controlled release lipoic acid
A controlled release formulation of lipoic acid is disclosed. The lipoic acid is combined with excipient materials in such a way that those materials provide for gradual release of the lipoic acid...
|
|
|
7115281 |
Processes for the preparation of oral dosage formulations of modafinil
The invention relates to processes for preparing, and pharmaceutical compositions of, modafinil dosage forms for oral administration. The dosage forms include a mixture of coarse and fine particles...
|
|
|
7115278 |
Proteoglycan compositions for the treatment of cardiovascular inflammatory diseases
Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory...
|
|
|
7112609 |
Nutritional supplements
The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provide improved...
|
|
|
7108859 |
Antineoplastic product, use and formulation thereof
An antineoplastic product is comprised of at least three dosages forms, each of which has a different release profile, with the C max for the antineoplastic product being reached in less than...
|
|
|
7108865 |
Controlled-release dosage forms of azithromycin
A controlled-release dosage form of azithromycin having an improved side effect profile; a process for preparing the dosage form; and a method of treating a microbial infection, comprising...
|
|
|
7108864 |
Tablet formation
Disclosed is a non-sustained release pharmaceutical tablet composition which comprises a rapidly precipitating drug in an amount from about 5 to about 60% and at least one member selected from the...
|
|
|
7105178 |
Cardiotonic composition
A cardiotonic composition includes micronized digoxin, hydrophilic polymer(s) and optionally pharmaceutically acceptable excipient(s) in the form of a tablet that releases not more than 50% digoxin...
|
|
|
7105174 |
Multiple-delayed release anti-neoplastic product, use and formulation thereof
An anti-neoplastic product is comprised of at least three delayed release dosages forms, each of which has a different release profile, with the C max for the anti-neoplastic product being reached...
|
|
|
7105172 |
Treatment of rosacea
Disclosed herein are methods for the treatment or prevention of rosacea in a patient, including administering a compound that inhibits one or more components of the bradykinin activation pathway in...
|
|
|
7105179 |
Crystal forms of azithromycin
The invention relates to novel crystal forms of azithromycin, an antibiotic useful in the treatment of infections.
|
|
|
7101569 |
Methods of administering levothyroxine pharmaceutical compositions
The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized...
|
|
|
7101565 |
Probiotic/prebiotic composition and delivery method
A prebiotic, composition comprising a probiotic and prebiotic, and method of delivering a probiotic, prebiotic or composition directly into the intestinal tract of a mammal are disclosed. The...
|
|
|
7101573 |
Simethicone solid oral dosage form
The present invention provides a composition for forming a compressed solid dosage form that is a free-flowing compressible admixture of simethicone, an adsorbant, and an optional active agent,...
|
|
|
7097851 |
Oral formulation for gastrointestinal drug delivery
An oral formulation for gastrointestinal drug delivery which comprises an adhesion site-controlling layer for attaching the formulation to the selected site in the digestive tract, a drug-carrying...
|
|
|
7094427 |
Combination immediate release controlled release levodopa/carbidopa dosage forms
The present invention relates to dosage forms of a combination of carbidopa and levodopa comprising both immediate release and controlled release components for the treatment of ailments associated...
|
|
|
7094426 |
Stable oral pharmaceutical dosage forms
The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such...
|
|
|
7087243 |
Pharmaceutical coating composition and method of use
A composition is disclosed comprising a polymer and a surfactant in a solvent exhibiting a common solubility for the polymer and the surfactant. The composition provides a dosage form for...
|
|
|
7087215 |
Methods of administering and enhancing absorption of pharmaceutical agents
Pharmaceutical compositions comprising a macromolecular pharmaceutical agent in mixed micellar form are disclosed. The mixed micelles are formed from an alkali metal alkyl sulfate, and at least...
|
|
|
7087242 |
Subcoated simulated capsule-like medicament
A simulated capsule-like medicament comprising a subcoating of a mixture of a water-soluble, film-forming polymer, e.g. hydroxypropylmethyl cellulose and a hydrophobic plasticizer, e.g. castor oil,...
|
|
|
7083805 |
Edible holographic products, particularly pharmaceuticals and methods and apparatus for producing same
An edible product such as a unit dosage form of a pharmaceutically active substance includes a layer of a material that can receive and retain a high resolution microrelief that can convey...
|
|
|
7083807 |
Pharmaceutical compositions for the controlled release of active substances
The invention relates to pharmaceutical compositions which can be administrated orally, allowing the controlled release of at least one active substance comprising
a) the said at least one active...
|
|
|
7083808 |
Controlled/modified release oral methylphenidate formulations
The invention is directed to oral modified/controlled release methylphenidate formulations which provide a rapid initial onset of effect and a prolonged duration of effect. Preferably, the peak...
|
|
|
7083804 |
Acid-gas absorbing tablet and method of use
An acid-gas absorbing tablet including in relatively sufficient proportions an adsorbent which may be activated carbon or silica gel or a mixture thereof, potassium carbonate,...
|
|
|
7081255 |
Antifungal compositions with improved bioavailability
The present invention is concerned with novel pharmaceutical compositions of itraconazole which can be administered to a mammal suffering from a fungal infection, whereby a single such dosage form...
|
|
|
7078065 |
Composition containing asiasari radix extracts for protecting brain cells and improving memory
The present invention discloses that fractions of Asiasari Radix extract have the ability to induce neuroprotection against AMPA (-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-induced...
|